We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: The Access MeMed BV assay is validated for use across Beckman Coulter’s installed base of DxI 9000 and Access 2 immunoassay analyzers (photo courtesy of Beckman Coulter)

Beckman Coulter Gains CE Mark for Rapid Assay Distinguishing Bacterial vs Viral Infections

Beckman Coulter has received CE mark for the Access MeMed BV assay, a host‑response test that rapidly differentiates bacterial and viral infections. More...
15 Apr 2026
Image: The Access MeMed BV assay is validated for use across Beckman Coulter’s installed base of DxI 9000 and Access 2 immunoassay analyzers (photo courtesy of Beckman Coulter)

Beckman Coulter Gains CE Mark for Rapid Assay Distinguishing Bacterial vs Viral Infections

Beckman Coulter has received CE mark for the Access MeMed BV assay, a host‑response test that rapidly differentiates bacterial and viral infections. More...
15 Apr 2026
Image: Dengue is among the most widespread mosquito-borne infections, yet early risk stratification can be difficult when symptoms overlap with other febrile illnesses (photo courtesy of Adobe Stock)

Urine-Based Assay Predicts Severe Dengue Risk Early

A new urine test measures two inflammation-associated proteins to predict severe dengue earlier, outperforming warning signs to guide triage. More...
14 Apr 2026
Image: Elecsys NfL is an in vitro quantitative immunoassay that measures neurofilament light chain protein concentrations in human serum and plasma (photo courtesy of Roche)

CE-Marked Blood Test Enables Monitoring of Neuroinflammation in Multiple Sclerosis

Roche’s Elecsys Neurofilament Light Chain (NfL) test has received CE mark approval for use in adults diagnosed with relapsing‑remitting multiple sclerosis (RRMS). More...
14 Apr 2026
Image: Personalis’ NeXT Personal ultrasensitive ctDNA assay will be featured alongside the debut of Real‑Time Variant Tracker at the AACR Annual Meeting 2026 in San Diego (photo courtesy of Personalis)

Ultrasensitive Assay Tracks Resistance Mutations MRD Monitoring

A new ctDNA MRD test tracks resistance mutations and detects down to 10 ppm to predict immunotherapy response and relapse. More...
14 Apr 2026
Image: ApoB is a blood test that counts the total number of harmful particles in circulation, providing a more complete assessment of risk (photo courtesy of Adobe Stock)

Study Finds ApoB Testing More Effective Than LDL for Guiding Lipid Therapy

New findings show apolipoprotein B (ApoB) testing better guides lipid therapy than LDL/non-HDL. More...
14 Apr 2026
Image: The findings suggest anemia may signal underlying disease, with routine blood tests helping identify patients needing closer follow-up (photo courtesy of 123RF)

Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality

New data show routine MCV-defined anemia phenotypes could indicate near-term cancer and mortality risk. More...
14 Apr 2026
New
Gold Member
Aspiration System
VACUSAFE
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
Total Laboratory Automation Solution
SATLARS Mini T8